Induced Angiogenesis by Genic Therapy in Advanced Ischemic Cardiomyopathy — THEANGIOGEN

Ischemic Cardiopathy Clinical Trial

Official title:
Induced Angiogenesis by Genic Therapy With VEGF165 in Advanced Ischemic Cardiomyopathy - Historical Controlled Trial

Status Unknown status

Clinical Trial Summary

Human Vascular Endothelial Grown Factor 165 (hVEGF165) administration is promising therapy induces a new vessels, arterioles and capillaries in regions whose revascularization surgery is not possible by direct or by percutaneous angioplasty. This study aims to evaluate the clinical effects and safety of gene therapy with hVEGF165 in patients with advanced coronary artery disease.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00744315
Study type	Interventional
Source	Instituto de Cardiologia do Rio Grande do Sul
Contact	Imarilde Giusti, MD
Phone	555132192802
Email	pesquisa@cardiologia.org.br
Status	Unknown status
Phase	Phase 2
Start date	November 2007
Completion date	May 2009

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00408044` - Dysesthesia Study After Sternotomy	N/A
	Not yet recruiting	`NCT05192005` - Perioperative Blood Pressure and In-hospital Morbidity After Coronary Artery Bypass Surgery